Apple Total Cost of Revenue decreased by 24.3% to $56.40B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.7%, from $50.49B to $56.40B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a 0.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $46.18B | $48.19B | $69.70B | $54.72B | $47.07B | $52.05B | $66.82B | $52.86B | $45.38B | $49.07B | $64.72B | $48.48B | $46.10B | $51.05B | $66.03B | $50.49B | $50.32B | $54.13B | $74.53B | $56.40B |
| QoQ Change | — | +4.3% | +44.7% | -21.5% | -14.0% | +10.6% | +28.4% | -20.9% | -14.1% | +8.1% | +31.9% | -25.1% | -4.9% | +10.7% | +29.3% | -23.5% | -0.3% | +7.6% | +37.7% | -24.3% |
| YoY Change | — | — | — | — | +1.9% | +8.0% | -4.1% | -3.4% | -3.6% | -5.7% | -3.1% | -8.3% | +1.6% | +4.0% | +2.0% | +4.1% | +9.2% | +6.0% | +12.9% | +11.7% |
| Segment | Q2 '26 |
|---|---|
| Americas | $23.11B |
| Europe | $13.76B |
| Greater China | $10.63B |
| Rest of Asia Pacific | $4.63B |
| Japan | $4.27B |
| Total | $56.40B |